ATP-binding cassette transporter A1: A cell cholesterol exporter that protects against cardiovascular disease

Physiological Reviews

Volumn 85, Issue 4, 2005, Pages 1343-1372

  Oram, John F ^a   Heinecke, Jay W ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; APOLIPOPROTEIN; HIGH DENSITY LIPOPROTEIN;

ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL FUNCTION; CELL PROTECTION; CELL STRUCTURE; CHOLESTEROL TRANSPORT; ENZYME DEFICIENCY; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC MANIPULATION; HUMAN; HUMAN CELL; LIPID TRANSPORT; LIPOPROTEIN METABOLISM; MACROPHAGE ACTIVATION; METABOLIC DISORDER; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; TARGET CELL; TRANSCRIPTION REGULATION;

ANIMALS; ANTILIPEMIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT, ACTIVE; CARDIOVASCULAR DISEASES; CHOLESTEROL; GENE EXPRESSION; HUMANS;

EID: 25444463073     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.00005.2005     Document Type: Review

References (312)

1. Abe-Dohmae S, Ikeda Y, Matsuo M, Hayashi M, Okuhira K, Ueda K, and Yokoyama S. Human ABCA7 supports apolipoprotein-mediated release of cellular cholesterol and phospholipid to generate high density lipoprotein. J Biol Chem 279: 604-611, 2004.
2. Abrass CK. Cellular lipid metabolism and the role of lipids in progressive renal disease. Am J Nephrol 24: 46-53, 2004.
3. Aiello EJ, Brees D, Bourassa PA, Royer L, Lindsey S, Coskran T, Haghpassand M, and Francone OL. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler Thromb Vasc Biol 22: 630-637, 2002.
4. Aiello RJ, Brees D, and Francone OL. ABCA1-deficient mice: insights into the role of monocyte lipid efflux in HDL formation and inflammation. Arterioscler Thromb Vasc Biol 23: 972-980, 2003.
5. Albers JJ, Wolfbauer G, Cheung MC, Day JH, Ching AF, Lok S, and Tu AY. Functional expression of human and mouse plasma phospholipid transfer protein: effect of recombinant and plasma PLTP on HDL subspecies. Biochim Biophys Acta 1258: 27-34, 1995.
6. Albrecht C, Baynes K, Sardini A, Schepelmann S, Eden EE, Davies SW, Higgins CF, Feher MD, Owen JS, and Soutar AK. Two novel missense mutations in ABCA1 result in altered trafficking and cause severe autosomal recessive HDL deficiency. Biochim Biophys Acta 1689: 47-57, 2004.
7. Anderson MM, Requena JR, Crowley JK, Thorpe SR, and Heinecke JW. The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl) lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. J Clin Invest 104: 103-113, 1999.
8. Anderson RG. The caveolae membrane system. Annu Rev Biochem 67: 199-225, 1998.
9. Arakawa R and Yokoyama S. Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol protease-mediated degradation. J Biol Chem 277: 22426-22429, 2002.
10. Argmann CA, Van Den Diepstraten CH, Sawyez CG, Edwards JY, Hegele RA, Wolfe BM, and Huff MW. Transforming growth factor-beta1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants. Arterioscler Thromb Vasc Biol 21: 2011-2018, 2001.
11. Assman G, von Eckardstein A, and Brewer HB. Familial high density lipoprotein deficiency: Tangier disease. In: The Metabolic and Molecular Bases of Inherited Disease, edited by Scriver CR, Beaudet AL, Sly WS, and Valle D. New York: McGraw-Hill, 1995, p. 2053-2072.
12. Asztalos BF and Roheim PS. Presence and formation of "free apolipoprotein A-I-like" particles in human plasma. Arterioscler Thromb Vasc Biol 15: 1419-1423, 1995.
13. Attie AD, Brooks-Wilson A, Gray-Keller ME, Zhang LH, Tebon A, Mulligan J, Bitgood JJ, Cook ME, Kastelein JJ, and Hayden MR. Massive cholesterol ester accumulation in hepatocytes and intestinal epithelial cells caused by ABC1 mutation in WHAM chickens. Circulation 102: II-312, 2000.
14. Bared SM, Buechler C, Boettcher A, Dayoub R, Sigruener A, Grandl M, Rudolph C, Dada A, and Schmitz G. Association of ABCA1 with syntaxin 13 and flotillin-1 and enhanced phagocytosis in tangier cells. Mol Biol Cell 15: 5399-5407, 2004.
15. Baynes JW and Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48: 1-9, 1999.
16. Bellosta S, Mahley KW, Sanan DA, Murata J, Newland DL, Taylor JM, and Pitas RB. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J Clin Invest 96: 2170-2179, 1995.
17. Berge KE, Tian H, Graf GA, Yu L, Grishin NV, Schultz J, Kwiterovich P, Shan B, Barnes R, and Hobbs HH. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290: 1771-1775, 2000.
18. Bergt C, Pennathur S, Fu X, Byun J, O'Brien K, McDonald TO, Singh P, Anantharamaiah GM, Chait A, Brunzell J, Geary RL, Oram JF, and Heinecke JW. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc Natl Acad Sci USA 101: 13032-13037, 2004.
19. Bierman EL. George Lyman Duff Memorial Lecture. Atherogenesis in diabetes. Arterioscler Thromb 12: 647-656, 1992.
20. Bjorkhem I and Meaney S. Brain cholesterol: long secret life behind a barrier. Arterioscler Thromb Vasc Biol 24: 806-815, 2004.
21. Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, Diederich W, Drobnik W, Barlage S, Buchler C, Porsch-Ozcurumez M, Kaminski WE, Hahmann HW, Oette K, Rothe G, Aslanidis C, Lackner KJ, and Schmitz G. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22: 347-351, 1999.
22. Bortnick AE, Favari E, Tao JQ, Francone OL, Reilly M, Zhang Y, Rothblat GH, and Bates SR. Identification and characterization of rodent ABCA1 in isolated type II pneumocytes. Am J Physiol Lung Cell Mol Physiol 285: L869-L878, 2003.
23. Bortnick AE, Rothblat GH, Stoudt G, Hoppe KL, Royer LJ, McNeish J, and Francone OL. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J Biol Chem 275: 28634-28640, 2000.
24. Brooks-Wilson A, Marcil M, Clee SM, Zhang LH, Roomp K, van Dam M, Yu L, Brewer C, Collins JA, Molhuizen HO, Loubser O, Ouelette BF, Fichter K, Ashbourne-Excoffon KJ, Sensen CW, Scherer S, Mott S, Denis M, Martindale D, Frohlich J, Morgan K, Koop B, Pimstone S, Kastelein JJ, and Hayden MR. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 22: 336-345, 1999.
25. Brousseau ME, Eberhart GP, Dupuis J, Asztalos BF, Goldkamp AL, Schaefer EJ, and Freeman MW. Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size. J Lipid Res 41: 1125-1135, 2000.
26. Brown MS and Goldstein JL. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci USA 96: 11041-11048, 1999.
27. Brown MS and Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 232: 34-47, 1986.
28. Brownlee M, Cerami A, and Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315-1321, 1988.
29. Buechler C, Boettcher A, Bared SM, Probst MC, and Schmitz G. The carboxy terminus of the ATP-binding cassette transporter A1 interacts with a beta2-syntrophin/utrophin complex. Biochem Biophys Res Commun 293: 759-765, 2002.
30. Buechler C, MaaBared S, Aslanidis C, Ritter M, Drobnik W, and Schmitz G. Molecular and functional interaction of the ATP binding cassette transporter A1 with Fas-associated death domain protein. J Biol Chem 13: 13, 2002.
31. Bungert S, Molday LL, and Molday RS. Membrane topology of the ATP binding cassette transporter ABCR and its relationship to ABC1 and related ABCA transporters: identification of N-linked glycosylation sites. J Biol Chem 276: 23539-23546, 2001.
32. Burgess JW, Kiss RS, Zheng H, Zachariah S, and Marcel YL. Trypsin-sensitive and lipid-containing sites of the macrophage extracellular matrix bind apolipoprotein A-I and participate in ABCA1-dependent cholesterol efflux. J Biol Chem 111: 31318-31326, 2002.
33. Chait A and Wight TN. Interaction of native and modified low-density lipoproteins with extracellular matrix. Curr Opin Lipidol 11: 457-463, 2000.
34. Chambenoit O, Hamon Y, Marguet D, Rigneault H, Rosseneu M, and Chimini G. Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter. J Biol Chem 276: 9955-9960, 2001.
35. Chang G. Structure of MsbA from Vibrio cholera: a multidrug resistance ABC transporter homolog in a closed conformation. J Mol Biol 330: 419-430, 2003.
36. Chang G and Roth CB. Structure of MsbA from E. coli: a homolog of the multidrug resistance ATP binding cassette (ABC) transporters. Science 293: 1793-1800, 2001.
37. Chawla A, Boisvert WA, Lee CH, Laffitte BA, Barak Y, Joseph SB, Liao D, Nagy L, Edwards PA, Curtiss LK, Evans RM, and Tontonoz P. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol Cell 1: 161-171, 2001.
38. Cheung MC, Brown BG, Wolf AC, and Albers JJ. Altered particle size distribution of apolipoprotein A-I-containing lipoproteine in subjects with coronary artery disease. J Lipid Res 32: 383-394, 1991.
39. Cheung MC, Wolf AC, Knopp RH, and Foster DM. Protein transfer between A-I-containing lipoprotein subpopulations: evidence of non-transferable A-I in particles with A-II. Biochim Biophys Acta 1165: 68-77, 1992.
40. Chiesa G, Monteggia E, Marchesi M, Lorenzon P, Laucello M, Lorusso V, Di Mario C, Karvouni E, Newton RS, Bisgaier CL, Franceschini G, and Sirtori CR. Recombinant apolipoprotein A-I (Milano) infusion into rabbit carotid artery rapidly removes lipid from fatty streaks. Circ Res 90: 974-980, 2002.
41. Chinetti G, Lestavel S, Bocher V, Remaley AT, Neve B, Torra IP, Teissier E, Minnich A, Jaye M, Duverger N, Brewer HB, Fruchart JC, Clavey V, and Staels B. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 1: 53-58, 2001.
42. Choi HY, Karten B, Chan T, Vance JE, Greer WL, Heidenreich RA, Garver WS, and Francis GA. Impaired ABCA1-dependent lipid efflux and hypoalphalipoproteinemia in human Niemann-pick type C disease. J Biol Chem 278: 32569-32577, 2003.
43. Christiansen-Weber TA, Voland JR, Wu Y, Ngo K, Roland BL, Nguyen S, Peterson PA, and Fung-Leung WP. Functional loss of ABCA1 in mice causes severe placental malformation, aberrant lipid distribution, and kidney glomerulonephritis as well as high-density lipoprotein cholesterol deficiency. Am J Pathol 157: 1017-1029, 2000.
44. Christison J, Karjalainen A, Brauman J, Bygrave F, and Stocker R. Rapid reduction and removal of HDL- but not LDL-associated cholesteryl ester hydroperoxides by rat liver perfused in situ. Biochem J 314: 739-742, 1996.
45. Chroni A, Liu T, Fitzgerald ML, Freeman MW, and Zannis VI. Cross-linking and lipid efflux properties of apoA-I mutants suggest direct association between apoA-I helices and ABCA1. Biochemistry 43: 2126-2139, 2004.
46. Claudel T, Leibowitz MD, Fievet C, Tailleux A, Wagner B, Repa JJ, Torpier G, Lobaccaro JM, Paterniti JR, Mangelsdorf DJ, Heyman RA, and Auwerx J. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor. Proc Natl Acad Sci USA 98: 2610-2615, 2001.
47. Clee SM, Kastelein JJ, van Dam M, Marcil M, Roomp K, Zwarts KY, Collins JA, Roelants R, Tamasawa N, Stulc T, Suda T, Ceska R, Boucher B, Rondeau C, DeSouich C, Brooks-Wilson A, Molhuizen HO, Frohlich J, Genest J Jr, and Hayden MR. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes. J Clin Invest 106: 1263-1270, 2000.
48. Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, and Hobbs HH. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305: 869-872, 2004.
49. Combes V, Coltel N, Alibert M, van Eck M, Raymond C, Juhan-Vague I, Grau GE, and Chimini G. ABCA1 gene deletion protects against cerebral malaria: potential pathogenic role of microparticles in neuropathology. Am J Pathol 166: 295-302, 2005.
50. Costet P, Lalanne F, Gerbod-Giannone MC, Molina JR, Fu X, Lund EG, Gudas LJ, and Tall AR. Retinoic acid receptor-mediated induction of ABCA1 in macrophages. Mol Cell Biol 23: 7756-7766, 2003.
51. Costet P, Luo Y, Wang N, and Tall AR. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 275: 28240-28245, 2000.
52. Crawford AR, Smith AJ, Hatch VC, Oude Elferink RP, Borst P, and Crawford JM. Hepatic secretion of phospholipid vesicles in the mouse critically depends on mdr2 or MDR3 P-glycoprotein expression. Visualization by electron microscopy. J Clin Invest 100: 2562-2567, 1997.
53. Daugherty A, Dunn JL, Rateri DL, and Heinecke JW. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 94: 437-444, 1994.
54. Dean M, Hamon Y, and Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J Lipid Res 42: 1007-1017, 2001.
55. Denis M, Haidar B, Marcil M, Bouvier M, Krimbou L, and Genest J. Characterization of oligomeric human ATP binding cassette transporter A1. Potential implications for determining the structure of nascent high density lipoprotein particles. J Biol Chem 279: 41529-41536, 2004.
56. Diaz MN, Frei B, Vita JA, and Keaney JF Jr. Antioxidants and atherosclerotic heart disease. N Engl J Med 337: 408-416, 1997.
57. Diederich W, Orso E, Drobnik W, and Schmitz G. Apolipoprotein AI and HDL(3) inhibit spreading of primary human monocytes through a mechanism that involves cholesterol depletion and regulation of CDC42. Atherosclerosis 159: 313-324, 2001.
58. Dietschy JM and Turley SD. Cholesterol metabolism in the brain. Curr Opin Lipidol 12: 105-112, 2001.
59. Domigan NM, Charlton TS, Duncan MW, Winterbourn CC, and Kettle AJF. Chlorination of tyrosyl residues in peptides by myeloperoxidase and human neutrophils. J Biol Chem 270: 16542-16548, 1995.
60. Drobnik W, Borsukova H, Bottcher A, Pfeiffer A, Liebisch G, Schutz GJ, Schindler H, and Schmitz G. Apo AI/ABCA1-dependent and HDL3-mediated lipid efflux from compositionally distinct cholesterol-based microdomains. Traffic 3: 268-278, 2002.
61. Duverger N, Ghalim N, Ailhaud G, Steinmetz A, Fruchart JC, and Castro G. Characterization of apoA-IV-containing lipoprotein particles isolated from human plasma and interstitial fluid. Arterioscler Thromb 13: 126-132, 1993.
62. Duverger N, Viglietta C, Berthou L, Emmanuel F, Tailleux A, Parmentier-Nihoul L, Laine B, Fievet C, Castro G, Fruchart JC, Houbebine LM, and Denefie P. Transgenic rabbits expressing human apolipoprotein A-I in the liver. Arterioscler Thromb Vasc Biol 16: 1424-1429, 1996.
63. Eiserich JP, Cross CE, Jones AD, Halliwell B, and van der Vliet A. Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. A novel mechanism for nitric oxide-mediated protein modification. J Biol Chem 271: 19199-19208, 1996.
64. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, and van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391: 393-397, 1998.
65. Engel T, Lueken A, Bode G, Hobohm U, Lorkowski S, Schlueter B, Rust S, Cullen P, Pech M, Assmann G, and Seedorf U. ADP-ribosylation factor (ARF)-like 7 (ARL7) is induced by cholesterol loading and participates in apolipoprotein AI-dependent cholesterol export. FEBS Lett 566: 241-246, 2004.
66. Feng B and Tabas I. ABCA1-mediated cholesterol efflux is defective in free cholesterol-loaded macrophages: mechanism involves enhanced ABCA1 degradation in a process requiring full NPC1 activity. J Biol Chem 277: 43271-43280, 2002.
67. Feng B, Zhang D, Kuriakose G, Devlin CM, Kockx M, and Tabas I. Niemann-Pick C heterozygosity confers resistance to lesional necrosis and macrophage apoptosis in murine atherosclerosis. Proc Natl Acad Sci USA 100: 10423-10428, 2003.
68. Field FJ, Born E, and Mathur SN. LXE/RXE ligand activation enhances basolateral efflux of beta-sitosterol in CaCo-2 cells. J Lipid Res 45: 905-913, 2004.
69. Fielding CJ and Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res 36: 211-228, 1995.
70. Fielding PE, Nagao K, Hakamata H, Chimini G, and Fielding CJ. A two-step mechanism for free cholesterol and phospholipid efflux from human vascular cells to apolipoprotein A-I. Biochemistry 39: 14113-14120, 2000.
71. 2-terminal signal anchor sequence that translocates the protein's first hydrophilic domain to the exoplasmic space. J Biol Chem 276: 15137-15145, 2001.
72. Fitzgerald ML, Morris AL, Chroni A, Mendez AJ, Zannis VI, and Freeman MW. ABCA1 and amphipathic apolipoproteins form high-affinity molecular complexes required for cholesterol efflux. J Lipid Res 45: 287-294, 2004.
73. Fitzgerald ML, Morris AL, Rhee JS, Andersson LP, Mendez AJ, and Freeman MW. Naturally occurring mutations in the largest extracellular loops of ABCA1 can disrupt its direct interaction with apolipoprotein A-I. J Biol Chem 277: 33178-33187, 2002.
74. Fitzgerald ML, Okuhira K, Short GF, 3rd Manning JJ, Bell SA, and Freeman MW. ATP-binding cassette transporter A1 contains a novel C-terminal VFVNFA motif that is required for its cholesterol efflux and ApoA-I binding activities. J Biol Chem 279: 48477-48485, 2004.
75. Francis GA, Knopp RH, and Oram JF. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. J Clin Invest 96: 78-87, 1995.
76. Francis GA, Oram JF, Heinecke JW, and Bierman EL. Oxidative tyrosylation of HDL enhances the depletion of cellular cholesteryl esters by a mechanism independent of passive sterol desorption. Biochemistry 35: 15188-15197, 1996.
77. Fredrickson DS, Altrocchi PH, Avioli LV, Goodman DS, and Goodman HC. Tangier disease-combined clinical staff conference at the National Institutes of Health. Ann Intern Med 55: 1016, 1961.
78. Frikke-Schmidt R, Nordestgaard BG, Jensen GB, and Tybjaerg-Hansen A. Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population. J Clin Invest 114: 1343-1353, 2004.
79. Fruchart JC, De Geteire C, Delfly B, and Castro GR. Apolipoprotein A-I-containing particles and reverse cholesterol transport: evidence for connection between cholesterol efflux and atherosclerosis risk. Atherosclerosis 110 Suppl: S35-S39, 1994.
80. Fu X, Menke JG, Chen Y, Zhou G, MacNaul KL, Wright SD, Sparrow CP, and Lund EG. 27-Hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J Biol Chem 276: 38378-38387, 2001.
81. Fukumoto H, Deng A, Irizarry MC, Fitzgerald ML, and Rebeck GW. Induction of the cholesterol transporter ABCA1 in central nervous system cells by liver X receptor agonists increases secreted Abeta levels. J Biol Chem 277: 48508-48513, 2002.
82. Gan X, Kaplan R, Menke JG, MacNaul K, Chen Y, Sparrow CP, Zhou G, Wright SD, and Cai TQ. Dual mechanisms of ABCA1 regulation by geranylgeranyl pyrophosphate. J Biol Chem 276: 48702-48708, 2001.
83. Garner B, Waldeck AR, Witting PK, Rye KA, and Stocker R. Oxidation of high density lipoproteine. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII. J Biol Chem 273: 6088-6095, 1998.
84. Garver WS, Heidenreich BA, Erickson RP, Thomas MA, and Wilson JM. Localization of the murine Niemann-Pick Cl protein to two distinct intracellular compartments. J Lipid Res 41: 673-687, 2000.
85. Gaut JP, Byun J, Tran HD, Lauber WM, Carroll JA, Hotchkiss RS, Belaaouaj A, and Heinecke JW. Myeloperoxidase produces nitrating oxidants in vivo. J Clin Invest 109: 1311-1319, 2002.
86. Gillotte KL, Zaiou M, Lund-Katz S, Anantharamaiah GM, Holvoet P, Dhoest A, Palgunachari MN, Segrest JP, Weisgraber KH, Rothblat GH, and Phillips MC. Apolipoprotein-mediated plasma membrane microsolubilization. Role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid. J Biol Chem 274: 2021-2028, 1999.
87. Gillotte-Taylor K, Nickel M, Johnson WJ, Francone OL, Holvoet P, Lund-Katz S, Rothblat GH, and Phillips MC. Effects of enrichment of fibroblasts with unesterified cholesterol on the efflux of cellular lipids to apolipoprotein A-I. J Biol Chem 277: 11811-11820, 2002.
88. Ginsberg HN. Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis. Diabetes Care 14: 839-855, 1991.
89. Glomb MA and Monnier VM. Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J Biol Chem 270: 10017-10026, 1995.
90. Glomset JA. The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res 9: 155-167, 1968.
91. Gonzalez-Navarro H, Nong Z, Freeman L, Bensadoun A, Peterson K, and Santamarina-Fojo S. Identification of mouse and human macrophages as a site of synthesis of hepatic lipase. J Lipid Res 43: 671-675, 2002.
92. Gotto AM. Antioxidants, statins, and atherosclerosis. J Am Coll Cardiol 41: 1205-1210, 2003.
93. Graf GA, Li WP, Gerard RD, Gelissen I, White A, Cohen JC, and Hobbs HH. Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface. J Clin Invest 110: 659-669, 2002.
94. Groen AK, Bloks VW, Bandsma RH, Ottenhoff R, Chimini G, and Kuipers F. Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL. J Clin Invest 108: 843-850, 2001.
95. Guyton JE and Klemp KF. Development of the lipid-rich core in human atherosclerosis. Arterioscler Thromb Vasc Biol 16: 4-11, 1996.
96. Haghpassand M, Bourassa PA, Francone OL, and Aiello RJ. Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. J Clin Invest 108: 1315-1320, 2001.
97. Haidar B, Denis M, Krimbou L, Marcil M, and Genest J Jr. cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts. J Lipid Res 43: 2087-2094, 2002.
98. Haidar B, Denis M, Marcil M, Krimbou L, and Genest J Jr. Apolipoprotein A-I activates cellular cAMP signaling through the ABCA1 transporter. J Biol Chem 279: 9963-9969, 2004.
99. Haidar B, Mott S, Boucher B, Lee CY, Marcil M, and Genest J Jr. Cellular cholesterol efflux is modulated by phospholipid-derived signaling molecules in familial HDL deficiency/Tangier disease fibroblasts. J Lipid Res 42: 249-257, 2001.
100. Hamon Y, Broccardo C, Chambenoit O, Luciani MF, Toti F, Chaslin S, Freyssinet JM, Devaux PF, McNeish J, Marguet D, and Chimini G. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat Cell Biol 2: 399-406, 2000.
101. Hamon Y, Luciani MF, Becq F, Verrier B, Rubartelli A, and Chimini G. Interleukin-1beta secretion is impaired by inhibitors of the ATP binding cassette transporter, ABC1. Blood 90: 2911-2915, 1997.
102. Hazen SL, Hsu FF, Mueller DM, Crowley JE, and Heinecke JW. Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J Clin Invest 98: 1283-1289, 1996.
103. Heinecke JW. Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis. Arterioscler Thromb Vasc Biol 21: 1261-1264, 2001.
104. Heinecke JW. Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis. Curr Opin Lipidol 8: 268-274, 1997.
105. Heinecke JW. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 141: 1-15, 1998.
106. Heinecke JW, Li W, Daehnke HL III, and Goldstein JA. Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J Biol Chem 268: 4069-4077, 1993.
107. Heinecke JW, Li W, Francis GA, and Goldstein JA. Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. J Clin Invest 91: 2866-2872, 1993.
108. Hirano K, Matsuura F, Tsukamoto K, Zhang Z, Matsuyama A, Takaishi K, Komuro R, Suehiro T, Yamashita S, Takai Y, and Matsuzawa Y. Decreased expression of a member of the Rho GTPase family, Cdc42Hs, in cells from Tangier disease: the small G protein may play a role in cholesterol efflux. FEBS Lett 484: 275-279, 2000.
109. Hirsch-Reinshagen V, Zhou S, Burgess BL, Bernier L, McIsaac SA, Chan JY, Tansley GH, Cohn JS, Hayden MR, and Wellington CL. Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain. J Biol Chem 279: 41197-41207, 2004.
110. Hoffman JS and Benditt EP. Changes in high density lipoprotein content following endotoxin administration in the mouse. Formation of serum amyloid protein-rich subfractions. J Biol Chem 257: 10510-10517, 1982.
111. Huang Y, von Eckardstein A, Wu S, Maeda N, and Assmann G. A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells. Proc Natl Acad Sci USA 91: 1834-1838, 1994.
112. Huang ZH, Lin CY, Oram JF, and Mazzone T. Sterol efflux mediated by endogenous macrophage ApoE expression is independent of ABCA1. Arterioscler Thromb Vasc Biol 21: 2019-2025, 2001.
113. Hurst JK and Barrette WC Jr. Leukocytic oxygen activation and microbicidal oxidative toxins. Grit Rev Biochem Mol Biol 24: 271-328, 1989.
114. Huszar D, Varban ML, Rinninger F, Feeley R, Arai T, Fairchild-Huntress V, Donovan MJ, and Tall AR. Increased LDL cholesterol and atherosclerosis in LDL receptor-deficient mice with attenuated expression of scavenger receptor Bl. Arterioscler Thromb Vasc Biol 20: 1068-1073, 2000.
115. Huuskonen J, Vishnu M, Pullinger CR, Fielding PE, and Fielding CJ. Regulation of ATP-binding cassette transporter A1 transcription by thyroid hormone receptor. Biochemistry 43: 1626-1632, 2004.
116. Ikeda Y, Abe-Dohmae S, Munehira Y, Aoki R, Kawamoto S, Furuya A, Shitara K, Amachi T, Kioka N, Matsuo M, Yokoyama S, and Ueda K. Posttranscriptional regulation of human ABCA7 and its function for the apoA-I-dependent lipid release. Biochem Biophys Res Commun 311: 313-318, 2003.
117. Inazu A, Koizumi J, and Mabuchi H. Cholesteryl ester transfer protein and atherosclerosis. Curr Opin Lipidol 11: 389-396, 2000.
118. Iqbal J, Anwar K, and Hussain MM. Multiple, independently regulated pathways of cholesterol transport across the intestinal epithelial cells. J Biol Chem 278: 31610-31620, 2003.
119. Ischiropoulos H. Biological selectivity and functional aspects of protein tyrosine nitration. Biochem Biophys Res Commun 305: 776-783, 2003.
120. Ito T. Physiological function of ABCG1. Drug News Perspect 16: 490-492, 2003.
121. Janowski BA, Grogan MJ, Jones SA, Wisely GB, Kliewer SA, Corey EJ, and Mangelsdorf DJ. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc Natl Acad Sci USA 96: 266-271, 1999.
122. Jansen H, Verhoeven AJ, and Sijbrands EJ. Hepatic lipase: a pro- or anti-atherogenic protein? J Lipid Res 43: 1352-1362, 2002.
123. Jauhiainen M, Metso J, Pahlman R, Blomqvist S, van Tol A, and Ehnholm C. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem 268: 4032-4036, 1993.
124. Javitt NB. 25R,26-Hydroxycholesterol revisited: synthesis, metabolism, and biologic roles. J Lipid Res 43: 665-670, 2002.
125. Jiang X, Francone OL, Bruce C, Milne R, Mar J, Walsh A, Breslow JL, and Tall AR. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. J Clin Invest 98: 2373-2380, 1996.
126. Jiang XC, Bruce C, Mar J, Lin M, Ji Y, Francone OL, and Tall AR. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J Clin Invest 103: 907-914, 1999.
127. Jiang XC, Qin S, Qiao C, Kawano K, Lin M, Skold A, Xiao X, and Tall AR. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Nat Med 7: 847-852, 2001.
128. Jick H, Zornberg GL, Jick SS, Seshadri S, and Drachmen DA. Statins and the risk of dementia. Lancet 356: 1627-1631, 2000.
129. Johnson AC, Yabu JM, Hanson S, Shah VO, and Zager RA. Experimental glomerulopathy alters renal cortical cholesterol, SR-B1, ABCA1, and HMG CoA reductase expression. Am J Pathol 162: 283-291, 2003.
130. Joseph SB, McKilligin E, Pei L, Watson MA, Collins AR, Laffitte BA, Chen M, Noh G, Goodman J, Hagger GN, Tran J, Tippin TK, Wang X, Lusis AJ, Hsueh WA, Law RE, Collins JL, Willson TM, and Tontonoz P. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc Natl Acad Sci USA 99: 7604-7609, 2002.
131. Joyce C, Freeman L, Brewer HB Jr, and Santamarina-Fojo S. Study of ABCA1 function in transgenic mice. Arterioscler Thromb Vasc Biol 23: 965-971, 2003.
132. Joyce CW, Amar MJ, Lambert G, Vaisman BL, Paigen B, Najib-Fruchart J, Hoyt RF Jr, Neufeld ED, Remaley AT, Fredrickson DS, Brewer HB Jr, and Santamarina-Fojo S. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice. Proc Natl Acad Sci USA 99: 407-412, 2002.
133. Kaminski WE, Orso E, Diederich W, Klucken J, Drobnik W, and Schmitz G. Identification of a novel human sterol-sensitive ATP-binding cassette transporter (ABCA7). Biochem Biophys Res Commun 273: 532-538, 2000.
134. Katzov H, Chalmers K, Palmgren J, Andreasen N, Johansson B, Cairns NJ, Gatz M, Wilcock GK, Love S, Pedersen NL, Brookes AJ, Blennow K, Kehoe PG, and Prince JA. Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism. Hum Mutat 23: 358-367, 2004.
135. Kees-Folts D and Diamond JR. Relationship between hyperlipidemia, lipid mediators, and progressive glomerulosclerosis in the nephrotic syndrome. Am J Nephrol 13: 365-375, 1993.
136. Kellner-Weibel G, Luke SJ, and Rothblat GH. Cytotoxic cellular cholesterol is selectively removed by apoA-I via ABCA1. Atherosclerosis 171: 235-243, 2003.
137. Kerr IM, Costa-Pereira AP, Lillemeier BF, and Strobl B. Of JAKs, STATs, blind watchmakers, jeeps and trains. FEBS Lett 546: 1-5, 2003.
138. Kielar D, Dietmaier W, Langmann T, Aslanidis C, Probst M, Naruszewicz M, and Schmitz G. Rapid quantification of human ABCA1 mRNA in various cell types and tissues by real-time reverse transcription-PCR. Clin Chem 47: 2089-2097, 2001.
139. + channels by interaction with a family of membrane-associated guanylate kinases. Nature 378: 85-88, 1995.
140. Kim WS, Fitzgerald ML, Kang K, Okuhira K, Bell SA, Manning JJ, Koehn SL, Lu N, Moore KJ, and Freeman MW. Abca7 null mice retain normal macrophage phosphatidylcholine and cholesterol efflux activity despite alterations in adipose mass and serum cholesterol levels. J Biol Chem 280: 3989-3995, 2005.
141. Knight BL, Patel DD, Humphreys SM, Wiggins D, and Gibbons GF. Inhibition of cholesterol absorption associated with a PPAR alpha-dependent increase in ABC binding cassette transporter A1 in mice. J Lipid Res 44: 2049-2058, 2003.
142. Koldamova RP, Lefterov IM, Ikonomovic MD, Skoko J, Lefterov PI, Isanski BA, DeKosky ST, and Lazo JS. 22R-Hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter a1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion. J Biol Chem 278: 13244-13256, 2003.
143. Krieger M. Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI. Annu Rev Biochem 68: 523-558, 1999.
144. Kruth HS, Comly ME, Butler JB, Vanier MT, Fink JK, Wenger DA, Patel S, and Pentchev PG. Type C Niemann-Pick disease. Abnormal metabolism of low density lipoprotein in homozygous and heterozygous fibroblasts. J Biol Chem 261: 16769-16774, 1986.
145. Laffitte BA, Joseph SB, Chen M, Castrillo A, Repa J, Wilpitz D, Mangelsdorf D, and Tontonoz P. The phospholipid transfer protein gene is a liver X receptor target expressed by macrophages in atherosclerotic lesions. Mol Cell Biol 23: 2182-2191, 2003.
146. Laffitte BA, Joseph SB, Walczak R, Pei L, Wilpitz DC, Collins JL, and Tontonoz P. Autoregulation of the human liver X receptor alpha promoter. Mol Cell Biol 21: 7558-7568, 2001.
147. Laffitte BA, Repa JJ, Joseph SB, Wilpitz DC, Kast HH, Mangelsdorf DJ, and Tontonoz P. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc Natl Acad Sci USA 98: 507-512, 2001.
148. Langmann T, Porsch-Ozcurumez M, Heimerl S, Probst M, Moehle C, Taher M, Borsukova H, Kielar D, Kaminski WE, Dittrich-Wengenroth E, and Schmitz G. Identification of sterol-independent regulatory elements in the human ATP-binding cassette transporter A1 promoter: role of Sp1/3, E-box binding factors, and an oncostatin M-responsive element. J Biol Chem 277: 14443-14450, 2002.
149. Lawn RM, Wade DP, Couse TL, and Wilcox JN. Localization of human ATP-binding cassette transporter 1 (abc1) in normal and atherosclerotic tissues. Arterioscler Thromb Vasc Biol 21: 378-385, 2001.
150. Lawn RM, Wade DP, Garvin MR, Wang X, Schwartz K, Porter JG, Seilhamer JJ, Vaughan AM, and Oram JF. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest 104: R25-R31, 1999.
151. Lee J, Shirk A, Oram JF, Lee SP, and Kuver R. Polarized cholesterol and phospholipid efflux in cultured gall-bladder epithelial cells: evidence for an ABCA1-mediated pathway. Biochem J 364: 475-484, 2002.
152. Lee J, Tauscher A, Seo DW, Oram JF, and Kuver R. Cultured gallbladder epithelial cells synthesize apolipoproteins a-I and E. Am J Physiol Gastrointest Liver Physiol 285: G630-G641, 2003.
153. Lee JY and Parks JS. ATP-binding cassette transporter AI and its role in HDL formation. Curr Opin Lipidol 16: 19-25, 2005.
154. Lee MH, Lu K, Hazard S, Yu H, Shulenin S, Hidaka H, Kojima H, Allikmets R, Sakuma N, Pegoraro R, Srivastava AK, Salen G, Dean M, and Patel SB. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet 27: 79-83, 2001.
155. Leeuwenburgh C, Rasmussen JE, Hsu FF, Mueller DM, Pennathur S, and Heinecke JW. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J Biol Chem 272: 3520-3526, 1997.
156. Le Goff W, Peng DQ, Settle M, Brubaker G, Morton RE, and Smith JD. Cyclosporin A traps ABCA1 at the plasma membrane and inhibits ABCA1-mediated lipid efflux to apolipoprotein A-I. Arterioscler Thromb Vasc Biol 24: 2155-2161, 2004.
157. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, and Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 270: 12953-12956, 1995.
158. Lewis PM, Dunn MP, McMahon JA, Logan M, Martin JF, St-Jacques B, and McMahon AP. Cholesterol modification of sonic hedgehog is required for long-range signaling activity and effective modulation of signaling by Ptc1. Cell 105: 599-612, 2001.
159. Li AC, Brown KK, Silvestre MJ, Willson TM, Palinski W, and Glass CK. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest 106: 523-531, 2000.
160. Li Q, Tsujita M, and Yokoyama S. Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux in macrophages. Biochemistry 36: 12045-12052, 1997.
161. Li Y, Tacey K, Doil L, van Luchene R, Garcia V, Rowland C, Schrodi S, Leong D, Lau K, Catanese J, Sninsky J, Nowotny P, Holmans P, Hardy J, Powell J, Lovestone S, Thal L, Owen M, Williams J, Goate A, and Grupe A. Association of ABCA1 with late-onset Alzheimer's disease is not observed in a case-control study. Neurosci Lett 366: 268-271, 2004.
162. Lin G and Bornfeldt KE. Cyclic AMP-specific phosphodiesterase 4 inhibitors promote ABCA1 expression and cholesterol efflux. Biochem Biophys Res Commun 290: 663-669, 2002.
163. Lin G and Oram JF. Apolipoprotein binding to protruding membrane domains during removal of excess cellular cholesterol. Atherosclerosis 149: 359-370, 2000.
164. Linsel-Nitschke P, Jehle AW, Shan J, Cao G, Bacic D, Lan D, Wang N, and Tall AR. Potential role of ABCA7 in cellular lipid efflux to apoA-1. J Lipid Res 46: 86-92, 2005.
165. Litchfield DW. Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem J 369: 1-15, 2003.
166. Liu L, Bortnick AE, Nickel M, Dhanasekaran P, Subbaiah PV, Lund-Katz S, Rothblat GH, and Phillips MC. Effects of apolipoprotein A-I on ATP-binding cassette transporter A1-mediated efflux of macrophage phospholipid and cholesterol: formation of nascent high density lipoprotein particles. J Biol Chem 278: 42976-42984, 2003.
167. Lu K, Lee MH, Hazard S, Brooks-Wilson A, Hidaka H, Kojima H, Ose L, Stalenhoef AF, Mietinnen T, Bjorkhem I, Bruckert E, Pandya A, Brewer HB Jr, Salen G, Dean M, Srivastava A, and Patel SB. Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am J Hum Genet 69: 278-290, 2001.
168. MacDonald DL, Terry TL, Agellon LB, Nation PN, and Francis GA. Administration of tyrosyl radical-oxidized HDL inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 23: 1583-1588, 2003.
169. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240: 622-630, 1988.
170. Maizel A, Tassetto M, Filhol O, Cochet C, Prochiantz A, and Joliot A. Engrailed homeoprotein secretion is a regulated process. Development 129: 3545-3553, 2002.
171. Major AS, Dove DE, Ishiguro H, Su YR, Brown AM, Liu L, Carter KJ, Linton MF, and Fazio S. Increased cholesterol efflux in apolipoprotein AI (ApoAI)-producing macrophages as a mechanism for reduced atherosclerosis in ApoAI((-/-)) mice. Arterioscler Thromb Vasc Biol 21: 1790-1795, 2001.
172. Marsche G, Hammer A, Oskolkova O, Kozarsky KF, Sattler W, and Malle E. Hypochlorite-modifled high density lipoprotein, a high affinity ligand to scavenger receptor class B, type I, impairs high density lipoprotein-dependent selective lipid uptake and reverse cholesterol transport. J Biol Chem 277: 32172-32179, 2002.
173. Martinez LO, Agerholm-Larsen B, Wang N, Chen W, and Tall AR. Phosphorylation of a pest sequence in ABCA1 promotes calpain degradation and is reversed by ApoA-I. J Biol Chem 278: 37368-37374, 2003.
174. McNeish J, Aiello EJ, Guyot D, Turi T, Gabel C, Aldinger C, Hoppe KL, Roach ML, Royer LJ, de Wet J, Broccardo C, Chimini G, and Francone OL. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. Proc Natl Acad Sci USA 97: 4245-4250, 2000.
175. Meir K, Kitsberg D, Alkalay I, Szafer F, Rosen H, Shpitzen S, Avi LB, Staels B, Fievet C, Meiner V, Bjorkhem I, and Leitersdorf E. Human sterol 27-hydroxylase (CYP27) overexpressor transgenic mouse model. Evidence against 27-hydroxycholesterol as a critical regulator of cholesterol homeostasis. J Biol Chem 277: 34036-34041, 2002.
176. Mendez AJ, Anantharamaiah GM, Segrest JP, and Oram JF. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. J Clin Invest 94: 1698-1705, 1994.
177. Mendez AJ, Lin G, Wade DP, Lawn RM, and Oram JF. Membrane lipid domains distinct from cholesterol/sphingomyelin-rich rafts are involved in the ABCA1-mediated lipid secretory pathway. J Biol Chem 276: 3158-3166, 2001.
178. Mendez AJ and Oram JF. Limited proteolysis of high density lipoprotein abolishes its interaction with cell-surface binding sites that promote cholesterol efflux. Biochim Biophys Acta 1346: 285-299, 1997.
179. Mendez AJ, Oram JF, and Bierman EL. Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. J Biol Chem 266: 10104-10111, 1991.
180. Miao B, Zondlo S, Gibbs S, Cromley D, Hosagrahara VP, Kirchgessner TG, Billheimer J, and Mukherjee R. Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator. J Lipid Res 45: 1410-1417, 2004.
181. Miyazaki A, Sakuma S, Morikawa W, Takiue T, Miake F, Terano T, Sakai M, Hakamata H, Sakamoto Y, and Natio M. Intravenous injection of rabbit apolipoprotein A-I inhibits the progression of atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 15: 1882-1888, 1995.
182. Moncada S, Palmer RM, and Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142, 1991.
183. Mulligan JD, Flowers MT, Tebon A, Bitgood JJ, Wellington C, Hayden MR, and Attie AD. ABCA1 is essential for efficient basolateral cholesterol efflux during the absorption of dietary cholesterol in chickens. J Biol Chem 278: 13356-13366, 2003.
184. Munehira Y, Ohnishi T, Kawamoto S, Furuya A, Shitara K, Imamura M, Yokota T, Takeda S, Amachi T, Matsuo M, Kioka N, and Ueda K. Alpha1-syntrophin modulates turnover of ABCA1. J Biol Chem 279: 15091-15095, 2004.
185. Murthy S, Born E, Mathur SN, and Field FJ. LXE/RXR activation enhances basolateral efflux of cholesterol in CaCo-2 cells. J Lipid Res 43: 1054-1064, 2002.
186. Nagano Y, Arai H, and Kita T. High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc Natl Acad Sci USA 88: 6457-6461, 1991.
187. Nagy L, Tontonoz P, Alvarez JG, Chen H, and Evans RM. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 93: 229-240, 1998.
188. 1 mRNAs/isoforms that stimulate cellular cholesterol efflux to high density lipoprotein. J Biol Chem 279: 45980-45989, 2004.
189. Natarajan P, Forte TM, Chu B, Phillips MC, Oram JF, and Bielicki JK. Identification of an apolipoprotein A-I structural element that mediates cellular cholesterol efflux and stabilizes ATP binding cassette transporter Al. J Biol Chem 279: 24044-24052, 2004.
190. Navab M, Anantharamaiah GM, Hama S, Garber DW, Chaddha M, Hough G, Lallone R, and Fogelman AM. Oral administration of an Apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation 105: 290-292, 2002.
191. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Datta G, Garber D, and Fogelman AM. Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal. Curr Opin Lipidol 15: 645-649, 2004.
192. Neufeld EB, Demosky SJ Jr, Stonik JA, Combs C, Remaley AT, Duverger N, Santamarina-Fojo S, and Brewer HB Jr. The ABCA1 transporter functions on the basolateral surface of hepatocytes. Biochem Biophys Res Commun 297: 974-979, 2002.
193. Neufeld EB, Remaley AT, Demosky SJ, Stonik JA, Cooney AM, Comly M, Dwyer NK, Zhang M, Blanchette-Mackie J, Santamarina-Fojo S, and Brewer HB Jr. Cellular localization and trafficking of the human ABCA1 transporter. J Biol Chem 276: 27584-27590, 2001.
194. Neufeld EB, Stonik JA, Demosky SJ Jr, Knapper CL, Combs CA, Cooney A, Comly M, Dwyer N, Blanchette-Mackie J, Remaley AT, Santamarina-Fojo S, and Brewer HB Jr. The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease. J Biol Chem 279: 15571-15578, 2004.
195. Neufeld EB, Wastney M, Patel S, Suresh S, Cooney AM, Dwyer NK, Roff CF, Ohno K, Morris JA, Carstea ED, Incardona JP, Strauss JF III, Vanier MT, Patterson MC, Brady RO, Pentchev PG, and Blanchette-Mackie EJ. The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. J Biol Chem 274: 9627-9635, 1999.
196. Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Yasin M, Eaton GM, Lauer MA, Sheldon WS, Grines CL, Halpern S, Crowe T, Blankenship JC, and Kerensky R. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 290: 2292-2300, 2003.
197. Nofer JR, Feuerborn K, Levkau B, Sokoll A, Seedorf U, and Assmann G. Involvement of Cdc42 signaling in apoA-I-induced cholesterol efflux. J Biol Chem 278: 53055-53062, 2003.
198. Ntambi JM and Miyazaki M. Recent insights into stearoyl-CoA desaturase-1. Curr Opin Lipidol 14: 255-261, 2003.
199. O'Brien KD, Vuletic S, McDonald TO, Wolfbauer G, Lewis K, Tu AY, Marcovina S, Wight TN, Chait A, and Albers JJ. Cell-associated and extracellular phospholipid transfer protein in human coronary atherosclerosis. Circulation 108: 270-274, 2003.
200. Ohama T, Hirano K, Zhang Z, Aoki R, Tsujii K, Nakagawa-Toyama Y, Tsukamoto K, Ikegami C, Matsuyama A, Ishigami M, Sakai N, Hiraoka H, Ueda K, Yamashita S, and Matsuzawa Y. Dominant expression of ATP-binding cassette transporter-1 on basolateral surface of Caco-2 cells stimulated by LXR/RXR ligands. Biochem Biophys Res Commun 296: 625-630, 2002.
201. Okuhira K, Tsujita M, Yamauchi Y, Abe-Dohmae S, Kato K, Handa T, and Yokoyama S. Potential involvement of dissociated apoA-I in the ABCA1-dependent cellular lipid release by HDL. J Lipid Res 45: 645-652, 2004.
202. Oldfield S, Lowry C, Ruddick J, and Lightman S. ABCG4: a novel human white family ABC-transporter expressed in the brain and eye. Biochim Biophys Acta 1591: 175-179, 2002.
203. Oram JF. ATP-binding cassette transporter A1 and cholesterol trafficking. Curr Opin Lipidol 13: 373-381, 2002.
204. Oram JF. HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol. Arterioscler Thromb Vasc Biol 23: 720-727, 2003.
205. Oram JF and Lawn RM. ABCA1: the gatekeeper for eliminating excess tissue cholesterol. J Lipid Res 42: 1173-1179, 2001.
206. Oram JF, Lawn RM, Garvin MR, and Wade DP. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J Biol Chem 275: 34508-34511, 2000.
207. Oram JF, Mendez AJ, Lymp J, Kavanagh TJ, and Halbert CL. Reduction in apolipoprotein-mediated removal of cellular lipids by immortalization of human fibroblasts and its reversion by cAMP: lack of effect with Tangier disease cells. J Lipid Res 40: 1769-1781, 1999.
208. Oram JF, Vaughan AM, and Stocker R. ATP-binding cassette transporter Al mediates cellular secretion of alpha-tocopherol. J Biol Chem 276: 39898-39902, 2001.
209. Oram JF, Wolfbauer G, Vaughan AM, Tang C, and Albers JJ. Phospholipid transfer protein interacts with and stabilizes ATP-binding cassette transporter Al and enhances cholesterol efflux from cells. J Biol Chem 278: 52379-52385, 2003.
210. Oram JF and Yokoyama S. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J Lipid Res 37: 2473-2491, 1996.
211. Orso E, Broccardo C, Kaminski WE, Bottcher A, Liebisch G, Drobnik W, Gotz A, Chambenoit O, Diederich W, Langmann T, Spruss T, Luciani MF, Rothe G, Lackner KJ, Chimini G, and Schmitz G. Transport of lipids from Golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice. Nat Genet 24: 192-196, 2000.
212. Osborne TF. Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. J Biol Chem 275: 32379-32382, 2000.
213. Osterud B and Bjorklid E. Role of monocytes in atherogenesis. Physiol Rev 83: 1069-1112, 2003.
214. Ou J, Tu H, Shan B, Luk A, DeBose-Boyd RA, Bashmakov Y, Goldstein JL, and Brown MS. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc Natl Acad Sci USA 98: 6027-6032, 2001.
215. Panagotopulos SE, Witting SR, Horace EM, Hui DY, Maiorano JN, and Davidson WS. The role of apolipoprotein A-I helix 10 in apolipoprotein-mediated cholesterol efflux via ATP-binding cassette transporter A1 (ABCA1). J Biol Chem 13: 13, 2002.
216. Panousis CG and Zuckerman SH. Interferon-gamma induces downregulation of Tangier disease gene (ATP-binding-cassette transporter 1) in macrophage-derived foam cells. Arterioscler Thromb Vasc Biol 20: 1565-1571, 2000.
217. Panzenbock U, Kritharides L, Raftery M, Rye KA, and Stocker R. Oxidation of methionine residues to methionine sulfoxides does not decrease potential antiatherogenic properties of apolipoprotein A-I. J Biol Chem 275: 19536-19544, 2000.
218. Panzenboeck U, Balazs Z, Sovic A, Hrzenjak A, Levak-Frank S, Wintersperger A, Malle E, and Sattler W. ABCA1 and SR-BI are modulators of reverse sterol transport at an in vitro blood-brain barrier constituted of porcine brain capillary endothelial cells. J Biol Chem 28: 28, 2002.
219. Parthasarathy S, Barnett J, and Fong LG. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1044: 275-283, 1990.
220. Passarelli M, Tang C, McDonald TO, O'Brien KD, Gerrity RG, Heinecke JW, and Oram JF. Advanced glycated end product precursors impair ABCA1-dependent cholesterol removal from cells. Diabetes 54: 2198-2205, 2005.
221. Pennathur S, Bergt C, Shao B, Byun J, Kassim SY, Singh P, Green PS, McDonald TO, Brunzell J, Chait A, Oram JF, O'Brien K, Geary RL, and Heinecke JW. Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species. J Biol Chem 279: 42977-42983, 2004.
222. Pentchev PG, Kruth HS, Comly ME, Butler JD, Vanier MT, Wenger DA, and Patel S. Type C Niemann-Pick disease. A parallel loss of regulatory responses in both the uptake and esteriflcation of low density lipoprotein-derived cholesterol in cultured fibroblasts. J Biol Chem 261: 16775-16780, 1986.
223. Porsch-Ozcurumez M, Langmann T, Heimerl S, Borsukova H, Kaminski WE, Drobnik W, Honer C, Schumacher C, and Schmitz G. The zinc finger protein 202 (ZNF202) is a transcriptional represser of ATP binding cassette transporter A1 (ABCA1) and ABCG1 gene expression and a modulator of cellular lipid efflux. J Biol Chem 276: 12427-12433, 2001.
224. Quinet EM, Savio DA, Halpern AR, Chen L, Miller CP, and Nambi P. Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor. J Lipid Res 45: 1929-1942, 2004.
225. Ramjeesingh M, Li C, Kogan I, Wang Y, Huan LJ, and Bear CE. A monomer is the minimum functional unit required for channel and ATPase activity of the cystic flbrosis transmembrane conductance regulator. Biochemistry 40: 10700-10706, 2001.
226. Remaley AT, Stonik JA, Demosky SJ, Neufeld EB, Bocharov AV, Vishnyakova TG, Eggerman TL, Patterson AP, Duverger NJ, Santamarina-Fojo S, and Brewer HB Jr. Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem Biophys Res Commun 280: 818-823, 2001.
227. Remaley AT, Thomas F, Stonik JA, Demosky SJ, Bark SE, Neufeld EB, Bocharov AV, Vishnyakova TG, Patterson AP, Eggerman TL, Santamarina-Fojo S, and Brewer HB. Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway. J Lipid Res 44: 828-836, 2003.
228. Repa JJ, Berge KE, Pomajzl C, Richardson JA, Hobbs H, and Mangelsdorf DJ. Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. J Biol Chem 277: 18793-18800, 2002.
229. Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro JM, Shimomura I, Shan B, Brown MS, Goldstein JL, and Mangelsdorf DJ. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes Dev 14: 2819-2830, 2000.
230. Repa JJ and Mangelsdorf DJ. Nuclear receptor regulation of cholesterol and bile acid metabolism. Curr Opin Biotechnol 10: 557-563, 1999.
231. Repa JJ, Turley SD, Lobaccaro JA, Medina J, Li L, Lustig K, Shan B, Heyman RA, Dietschy JM, and Mangelsdorf DJ. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289: 1524-1529, 2000.
232. Rigot V, Hamon Y, Chambenoit O, Alibert M, Duverger N, and Chimini G. Distinct sites on ABCA1 control distinct steps required for cellular release of phospholipids. J Lipid Res 43: 2077-2086, 2002.
233. Roosbeek S, Peelman F, Verhee A, Labeur C, Caster H, Lensink MF, Cirulli C, Grooten J, Cochet C, Vandekerckhove J, Amoresano A, Chimini G, Tavernier J, and Rosseneu M. Phosphorylation by protein kinase CK2 modulates the activity of the ATP binding cassette A1 transporter. J Biol Chem 279: 37779-37788, 2004.
234. Rosenberg MF, Callaghan R, Ford RC, and Higgins CF. Structure of the multidrug resistance P-glycoprotein to 2.5 run resolution determined by electron microscopy and image analysis. J Biol Chem 272: 10685-10694, 1997.
235. Rosenberg MF, Kamis AB, Callaghan R, Higgins CF, and Ford RC. Three-dimensional structures of the mammalian multidrug resistance P-glycoprotein demonstrate major conformational changes in the transmembrane domains upon nucleotide binding. J Biol Chem 278: 8294-8299, 2003.
236. Rosenberg MF, Mao Q, Holzenburg A, Ford RC, Deeley RG, and Cole SP. The structure of the multidrug resistance protein 1 (MRP1/ABCC1). Crystallization and single-particle analysis. J Biol Chem 276: 16076-16082, 2001.
237. Rothblat GH, de la Llera-Moya M, Atger V, Kellner-Weibel G, Williams DL, and Phillips MC. Cell cholesterol efflux: integration of old and new observations provides new insights. J Lipid Res 40: 781-796, 1999.
238. Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, and Clift SM. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature 353: 265-267, 1991.
239. Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette JC, Deleuze JF, Brewer HB, Duverger N, Denefle P, and Assmann G. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 22: 352-355, 1999.
240. Rye KA and Barter PJ. Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I. Arterioscler Thromb Vasc Biol 24: 421-428, 2004.
241. Salmon S, Maziere C, Auclair M, Theron L, Santus R, and Maziere JC. Malondialdehyde modification and copper-induced autooxidation of high-density lipoprotein decrease cholesterol efflux from human cultured fibroblasts. Biochim Biophys Acta 1125: 230-235, 1992.
242. Santamarina-Fojo S, Remaley AT, Neufeld EB, and Brewer HB Jr. Regulation and intracellular trafficking of the ABCA1 transporter. J Lipid Res 42: 1339-1345, 2001.
243. Sarno S, Moro S, Meggio F, Zagotto G, Dal Ben D, Ghisellini P, Battistutta R, Zanotti G, and Pinna LA. Toward the rational design of protein kinase casein kinase-2 inhibitors. Pharmacol Ther 93: 159-168, 2002.
244. Schmitz G, Langmann T, and Heimerl S. Role of ABCG1 and other ABCG family members in lipid metabolism. J Lipid Res 42: 1513-1520, 2001.
245. Schultz JR, Tu H, Luk A, Repa JJ, Medina JC, Li L, Schwendner S, Wang S, Thoolen M, Mangelsdorf DJ, Lustig KD, and Shan B. Role of LXRs in control of lipogenesis. Genes Dev 14: 2831-2838, 2000.
246. Schwartz CC, Halloran LG, Vlahcevic ZR, Gregory DH, and Swell L. Preferential utilization of free cholesterol from high-density lipoproteins for biliary cholesterol secretion in man. Science 200: 62-64, 1978.
247. Schwartz K, Lawn RM, and Wade DP. ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. Biochem Biophys Res Commun 274: 794-802, 2000.
248. See RH, Caday-Malcolm RA, Singaraja RR, Zhou S, Silverston A, Huber MT, Moran J, James ER, Janoo R, Savill JM, Rigot V, Zhang LH, Wang M, Chimini G, Wellington CL, Tafuri SR, and Hayden MR. PKA site-specific phosphorylation regulates ABCA1-mediated phospholipid efflux. J Biol Chem 277: 41835-41842, 2002.
249. Segrest JP, Jones MK, De Loof H, Brouillette CG, Venkatachalapathi YV, and Anantharamaiah GM. The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function. J Lipid Res 33: 141-166, 1992.
250. Selva DM, Hirsch-Reinshagen V, Burgess B, Zhou S, Chan J, McIsaac S, Hayden MR, Hammond GL, Vogl AW, and Wellington CL. The ATP-binding cassette transporter 1 mediates lipid efflux from Sertoli cells and influences male fertility. J Lipid Res 45: 1040-1050, 2004.
251. Serfaty-Lacrosniere C, Civeira F, Lanzberg A, Isaia P, Berg J, Janus ED, Smith MP Jr, Pritchard PH, Frohlich J, Lees RS, Barnard GF, Ordovas JM, and Schaefer EJ. Homozygous Tangier disease and cardiovascular disease. Atherosclerosis 107: 85-98, 1994.
252. Shah PK, Yano J, Reyes O, Chyu KY, Kaul S, Bisgaier CL, Drake S, and Cercek B. High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization. Circulation 103: 3047-3050, 2001.
253. Shao B, Bergt C, Fu X, Green P, Voss JC, Oda MN, Oram JF, and Heinecke JW. Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport. J Biol Chem. 280: 5983-5993, 2005.
254. Silver DL and Tall AR. The cellular biology of scavenger receptor class B type I. Curr Opin Lipidol 12: 497-504, 2001.
255. Singaraja RR, Brunham LR, Visscher H, Kastelein JJ, and Hayden MR. Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler Thromb Vasc Biol 23: 1322-1332, 2003.
256. Singaraja RR, Fievet C, Castro G, James ER, Hennuyer N, Clee SM, Bissada N, Choy JC, Fruchart JC, McManus BM, Staels B, and Hayden MR. Increased ABCA1 activity protects against atherosclerosis. J Clin Invest 110: 35-42, 2002.
257. Smith JD, Waelde C, Horwitz A, and Zheng P. Evaluation of the role of phosphatidylserine translocase activity in ABCA1-mediated lipid efflux. J Biol Chem 277: 17797-17803, 2002.
258. Stonik JA, Remaley AT, Demosky SJ, Neufeld EB, Bocharov A, and Brewer HB. Serum amyloid A promotes ABCA1-dependent and ABCA1-independent lipid efflux from cells. Biochem Biophys Res Commun 321: 936-941, 2004.
259. Sun Y, Yao J, Kim TW, and Tall AR. Expression of liver X receptor target genes decreases cellular amyloid beta peptide secretion. J Biol Chem 278: 27688-27694, 2003.
260. Suzuki S, Nishimaki-Mogami T, Tamehiro N, Inoue K, Arakawa R, Abe-Dohmae S, Tanaka AR, Ueda K, and Yokoyama S. Verapamil increases the apolipoprotein-mediated release of cellular cholesterol by induction of ABCA1 expression via liver X receptor-independent mechanism. Arterioscler Thromb Vasc Biol 24: 519-525, 2004.
261. Takahashi Y and Smith JD. Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calcium-dependent pathway. Proc Natl Acad Sci USA 96: 11358-11363, 1999.
262. Takai Y, Sasaki T, and Matozaki T. Small GTP-binding proteins. Physiol Rev 81: 153-208, 2001.
263. Tanaka AR, Abe-Dohmae S, Ohnishi T, Aoki R, Morinaga G, Okuhira K, Ikeda Y, Kano F, Matsuo M, Kioka N, Amachi T, Murata M, Yokoyama S, and Ueda K. Effects of mutations of ABCA1 in the first extracellular domain on subcellular trafficking and ATP binding/hydrolysis. J Biol Chem 278: 8815-8819, 2003.
264. Tang C, Vaughan AM, and Oram JF. Janus kinase 2 modulates the apolipoprotein interactions with ABCA1 required for removing cellular cholesterol. J Biol Chem 279: 7622-7628, 2004.
265. Tangirala RK, Tsukamoto K, Chun SH, Usher D, Pure E, and Rader DJ. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. Circulation 100: 1816-1822, 1999.
266. Theret N, Delbart C, Aguie G, Fruchart JC, Vassaux G, and Ailhaud G. Cholesterol efflux from adipose cells is coupled to diacylglycerol production and protein kinase C activation. Biochem Biophys Res Commun 173: 1361-1368, 1990.
267. Thornalley PJ, Langborg A, and Minhas HS. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem J 344: 109-116, 1999.
268. Tontonoz P and Mangelsdorf DJ. Liver X receptor signaling pathways in cardiovascular disease. Mol Endocrinol 17: 985-993, 2003.
269. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, and Evans RM. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93: 241-252, 1998.
270. Tsukamoto K, Hirano K, Tsujii K, Ikegami C, Zhongyan Z, Nishida Y, Ohama T, Matsuura F, Yamashita S, and Matsuzawa Y. ATP-binding cassette transporter-1 induces rearrangement of actin cytoskeletons possibly through Cdc42/N-WASP. Biochem, Biophys Res Commun 287: 757-765, 2001.
271. Tu AY, Nishida HI, and Nishida T. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J Biol Chem 268: 23098-23105, 1993.
272. Uehara Y, Engel T, Li Z, Goepfert C, Rust S, Zhou X, Langer C, Schachtrup C, Wiekowski J, Lorkowski S, Assmann G, and Von Eckardstein A. Polyunsaturated fatty acids and acetoacetate downregulate the expression of the ATP-binding cassette transporter A1. Diabetes 51: 2922-2928, 2002.
273. Van Dam MJ, de Groot E, Clee SM, Hovingh GK, Roelants R, Brooks-Wilson A, Zwinderman AH, Smit AJ, Smelt AH, Groen AK, Hayden MR, and Kastelein JJ. Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study. Lancet 359: 37-42, 2002.
274. Van Eck M, Bos IS, Kaminski WE, Orso E, Rothe G, Twisk J, Bottcher A, Van Amersfoort ES, Christiansen-Weber TA, Fung-Leung WP, Van Berkel TJ, and Schmitz G. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc Natl Acad Sci USA 99: 6298-6303, 2002.
275. Van Lenten BJ, Navab M, Shih D, Fogelman AM, and Lusis AJ. The role of high-density lipoproteins in oxidation and inflammation. Trends Cardiovasc Med 11: 155-161, 2001.
276. Vaughan AM and Oram JF. ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions. J Lipid Res 44: 1373-1380, 2003.
277. Vedhachalam C, Liu L, Nickel M, Bhanasekaran P, Anantharamaiah GM, Lund-Katz S, Rothblat GH, and Phillips MC. Influence of ApoA-I structure on the ABCA1-mediated efflux of cellular lipids. J Biol Chem 279: 49931-49939, 2004.
278. Von Eckardstein A, Huang Y, Wu S, Funke H, Noseda G, and Assmann G. Reverse cholesterol transport in plasma of patients with different forms of familial HDL deficiency. Arterioscler Thromb Vasc Biol 15: 691-703, 1995.
279. Von Eckardstein A, Langer C, Engel T, Schaukai I, Cignarella A, Reinhardt J, Lorkowski S, Li Z, Zhou X, Cullen P, and Assmann G. ATP binding cassette transporter ABCA1 modulates the secretion of apolipoprotein E from human monocyte-derived macrophages. FASEB J 15: 1555-1561, 2001.
280. Wahrle SE, Jiang H, Parsadanian M, Legleiter J, Han X, Fryer JD, Kowalewski T, and Holtzman DM. ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE. J Biol Chem 279: 40987-40993, 2004.
281. Walter M, Reinecke H, Gerdes U, Nofer JR, Hobbel G, Seedorf U, and Assmann G. Defective regulation of phosphatidylcholine-specific phospholipases C and D in a kindred with Tangier disease. Evidence for the involvement of phosphatidylcholine breakdown in HDL-mediated cholesterol efflux mechanisms. J Clin Invest 98: 2315-2323, 1996.
282. Walter M, Reinecke H, Nofer JR, Seedorf U, and Assmann G. HDL3 stimulates multiple signaling pathways in human skin fibroblasts. Arterioscler Thromb Vasc Biol 15: 1975-1986, 1995.
283. Wang N, Chen W, Linsel-Nitschke P, Martinez LO, Agerholm-Larsen B, Silver DL, and Tall AR. A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. J Clin Invest 111: 99-107, 2003.
284. Wang N, Lan D, Chen W, Matsuura F, and Tall AR. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci USA 101: 9774-9779, 2004.
285. Wang N, Lan D, Gerbod-Giannone M, Linsel-Nitschke P, Jehle AW, Chen W, Martinez LO, and Tall AR. ATP-binding cassette transporter A7 (ABCA7) binds apolipoprotein A-I and mediates cellular phospholipid but not cholesterol efflux. J Biol Chem 278: 42906-42912, 2003.
286. Wang N, Silver DL, Thiele C, and Tall AR. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J Biol Chem 276: 23742-23747, 2001.
287. Wang N and Tall AR. Regulation and mechanisms of ATP-binding cassette transporter al-mediated cellular cholesterol efflux. Arterioscler Thromb Vasc Biol 23: 1178-1184, 2003.
288. Wang WQ, Merriam DL, Moses AS, and Francis GA. Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers. J Biol Chem 273: 17391-17398, 1998.
289. Wang Y, Kurdi-Haidar B, and Oram JF. LXR-mediated activation of macrophage stearoyl-CoA desaturase generates unsaturated fatty acids that destabilize ABCA1. J Lipid Res 45: 972-980, 2004.
290. Wang Y and Oram JF. Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter A1. J Biol Chem 111: 5692-5697, 2002.
291. 2 pathway. Arterioscler Thromb Vasc Biol 25: E47, 2005.
292. Warden CH, Hedrick CC, Qiao JH, Castellani LW, and Lusis AJ. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science 261: 469-472, 1993.
293. Wellington CL. Cholesterol at the crossroads: Alzheimer's disease and lipid metabolism. Clin Genet 66: 1-16, 2004.
294. Wellington CL, Brunham LR, Zhou S, Singaraja RR, Visscher H, Gelfer A, Ross C, James E, Liu G, Huber MT, Yang YZ, Parks RJ, Groen A, Fruchart-Najib J, and Hayden MR. Alterations of plasma lipids in mice via adenoviral-mediated hepatic overexpression of human ABCA1. J Lipid Res 44: 1470-1480, 2003.
295. Wellington CL, Walker EK, Suarez A, Kwok A, Bissada N, Singaraja R, Yang YZ, Zhang LH, James E, Wilson JE, Francone O, McManus BM, and Hayden MR. ABCA1
296. Whitney KD, Watson MA, Goodwin B, Galardi CM, Maglich JM, Wilson JG, Willson TM, Collins JTL, and Kliewer SA. Liver X receptor (LXR) regulation of the LXRalpha gene in human macrophages. J Biol Chem 276: 43509-43515, 2001.
297. Witting SR, Maiorano JN, and Davidson WS. Ceramide enhances cholesterol efflux to apolipoprotein A-I by increasing the cell surface presence of ATP-binding cassette transporter A1. J Biol Chem 278: 40121-40127, 2003.
298. Witztum JL and Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88: 1785-1792, 1991.
299. Wolff SP and Dean RT. Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem J 245: 243-250, 1987.
300. Wollmer MA, Streffer JR, Lutjohann D, Tsolaki M, Iakovidou V, Hegi T, Pasch T, Jung HH, Bergmann K, Nitsch RM, Hock C, and Papassotiropoulos A. ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease. Neurobiol Aging 24: 421-426, 2003.
301. Wolozin B, Brown J, Theisler C III, and Silberman S. The cellular biochemistry of cholesterol and statins: insights into the pathophysiology and therapy of Alzheimer's disease. CNS Drug Rev 10: 127-146, 2004.
302. Wu J, Zhang Y, Wang N, Davis L, Yang G, Wang X, Zhu Y, Breyer MD, and Guan Y. Liver X receptor-alpha mediates cholesterol efflux in glomerular mesangial cells. Am J Physiol Renal Physiol 287: F886-F895, 2004.
303. Yamauchi Y, Chang CC, Hayashi M, Abe-Dohmae S, Reid PC, Chang TY, and Yokoyama S. Intracellular cholesterol mobilization involved in the ABCA1/apolipoprotein-mediated assembly of high density lipoprotein in flbroblasts. J Lipid Res 45: 1943-1951, 2004.
304. Yamauchi Y, Hayashi M, Abe-Dohmae S, and Yokoyama S. ApoA-I activates PKCalpha signaling to phosphorylate and stabilize ABCA1 for the HDL assembly. J Biol Chem. 278: 47890-47897, 2003.
305. Yancey PG, Bielicki JK, Johnson WJ, Lund-Katz S, Palgunachari MN, Anantharamaiah GM, Segrest JP, Phillips MC, and Rothblat GH. Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry 34: 7955-7965, 1995.
306. Yang XP, Freeman LA, Knapper CL, Amar MJ, Remaley A, Brewer HB Jr, and Santamarina-Fojo S. The E-box motif in the proximal ABCA1 promoter mediates transcriptional repression of the ABCA1 gene. J Lipid Res 43: 297-306, 2002.
307. Zeng L, Liao H, Liu Y, Lee TS, Zhu M, Wang X, Stemerman MB, Zhu Y, and Shyy JY. Sterol-responsive element-binding protein (SREBP) 2 down-regulates ATP-binding cassette transporter A1 in vascular endothelial cells: a novel role of SREBP in regulating cholesterol metabolism. J Biol Chem 279: 48801-48807, 2004.
308. Zha X, Gauthier A, Genest J, and McPherson R. Secretory vesicular transport from the Golgi is altered during ATP-binding cassette protein A1 (ABCA1) mediated cholesterol efflux. J Biol Chem 278: 10002-10005, 2003.
309. Zheng L, Nukuna B, Brennan ML, Sun M, Goormastic M, Settle M, Schmitt D, Fu X, Thomson L, Fox PL, Ischiropoulos H, Smith JD, Kinter M, and Hazen SL. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 114: 529-541, 2004.
310. Zheng L, Settle M, Brubaker G, Schmitt D, Hazen SL, Smith JD, and Kinter M. Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages. J Biol Chem 280: 38-47, 2005.
311. Zhou J, You Y, Ryan AJ, and Mallampalli RK. Upregulation of surfactant synthesis triggers ABCA1-mediated basolateral phospholipid efflux. J Lipid Res 45: 1758-1767, 2004.
312. Zhou X, Engel T, Goepfert C, Erren M, Assmann G, and von Eckardstein A. The ATP binding cassette transporter A1 contributes to the secretion of interleukin 1beta from macrophages but not from monocytes. Biochem Biophys Res Commun 291: 598-604, 2002.